secwatch.observer — SEC 8-K summary
======================================

Issuer:     Lifeloc Technologies, Inc (LCTC)
CIK:        0001493137
Form:       8-K
Filed at:   2023-05-09T23:59:59+00:00
Accession:  0001079973-23-000641
Event type: earnings
Sentiment:  positive
Materiality: 0.55
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Lifeloc Q1 net loss narrows to $54K; revenue flat at $2.165M
------------------------------------------------------------

- Net revenue $2.165M flat YoY; net loss $(54)K ($0.02/sh) vs $(145)K loss ($0.06/sh) in Q1 2022.
- Gross margin improved to 43.2% from 39.0% YoY, driven by price increases and lower depreciation.
- R&D spending increased for SpinDx THC saliva testing platform; commercialization expected in 2024.
- Supply chain constraints held back sales but component lead times shortening; backlog expected to be fulfilled in Q2.
- Company implemented additional price increases for 2023 to offset component inflation.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1493137/000107997323000641/0001079973-23-000641-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1493137/000107997323000641/lclc_8k.htm
  HTML page:      https://secwatch.observer/filing/0001079973-23-000641

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer